Cellectis (CLLS) Cash & Current Investments (2013 - 2026)

Cellectis' Cash & Current Investments history runs 14 years deep, the most recent figure standing at $185.7 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 23.81% year-over-year to $185.7 million; the TTM figure through Mar 2026 stood at $185.7 million (down 23.81% YoY), while the FY2025 annual figure was $208.7 million, down 48.87% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $185.7 million, down from $208.7 million in the prior quarter.
• The five-year high for Cash & Current Investments was $408.1 million in Q4 2024, with the low at $67.4 million in Q3 2023.
• The 5-year median for Cash & Current Investments is $195.6 million (2022), against an average of $199.6 million.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments soared 287.4% in 2024, then slumped 48.87% in 2025.
• Cellectis' Cash & Current Investments stood at $195.6 million in 2022, then jumped by 76.45% to $345.2 million in 2023, then rose by 18.23% to $408.1 million in 2024, then plunged by 48.87% to $208.7 million in 2025, then retreated by 11.02% to $185.7 million in 2026.
• Business Quant data shows CLLS's Cash & Current Investments at $185.7 million in Q1 2026, $208.7 million in Q4 2025, and $192.2 million in Q3 2025.